GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer - Germany
doi 10.1007/s10120-019-00943-x
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2019
Authors
Publisher
Springer Science and Business Media LLC